Activated versions of the similar GTPases, H-Ras and RRas, have diering eects on biological phenotypes: Activated H-Ras strongly transforms many ®broblast cell lines causing dramatic changes in cell shape and cytoskeletal organization. In contrast, R-Ras transforms fewer cell lines and the transformed cells display only some of the morphological changes associated with HRas transformation. H-Ras cells can survive in the absence of serum whereas R-Ras cells seem to die by an apoptotic-like mechanism in response to removal of serum. H-Ras can suppress integrin activation and R-Ras speci®cally antagonizes this eect. To map sequences responsible for these dierences we have generated and investigated a panel of H-Ras and R-Ras chimeras. We found that the C-terminal 53 amino acids of R-Ras were necessary and sucient to specify the contrasting biological properties of R-Ras with respect to focus morphology, reactive oxygen species (ROS) production and reversal of H-Ras-induced integrin suppression. Surprisingly, we found chimeras in which the focus formation and integrin-mediated phenotypes were separated, suggesting that dierent eectors could be involved in mediating these responses. An integrin pro®le of HRas and R-Ras cell pools showed no signi®cant dierences; both activated H-Ras and R-Ras expressing cells were found to have reduced b 1 activity, suggesting that the activity state of the b 1 subunit is not sucient to direct an H-Ras transformed cell morphology.
Introduction
Ras GTPases are founder members of the Ras superfamily of small GTPases and function as molecular switches in the transduction of extracellular signals involved in cell growth and proliferation (Lowy and Willumsen, 1993) . R-Ras belongs to this superfamily and is approximately 55% identical to H-Ras . The main sequence divergence between H-Ras and R-Ras, and also between the Ras isoforms themselves, is con®ned to the C-terminus and speci®cally to the 26 amino acids of the carboxylterminal hypervariable region. The C-terminal 9 amino acids of H-Ras comprise the signal sequences for attaching it to the plasma membrane by fatty acid residues; the anchoring includes farnesylation and palmitoylation of the protein. R-Ras is also palmitoylated but possesses a dierent C-terminal prenylation motif for post-translational modi®cation and is geranyl-geranylated rather than farnesylated.
Despite the sequence similarities, activated versions of H-Ras and R-Ras confer distinct biological properties when expressed in mammalian cells. RRas is unable to transform Rat-1 ®broblasts and furthermore, R-Ras transformed NIH3T3 do not display all of the morphological eects associated with H-Ras transformed cells Cox et al., 1994; Saez et al., 1994) . Mutations in eector domains of both H-Ras and R-Ras show that these conserved sequences are required for transformation (White et al., 1995; Khosravi-Far et al., 1996; Osada et al., 1999) . The H-Ras eectors Raf, PI3-kinase and RalGDS have been shown to play a role in H-Ras transformation (White et al., 1995 Khosravi-Far et al., 1996; Urano et al., 1996; Rodriguez-Viciana et al., 1997) , and R-Ras has been found to activate and induce the elevation of the levels of PI3-kinase lipid products in vivo to the same degree as H-Ras (Marte et al., 1996) . Besides a potential role of PI3-kinase, it is not clear through which signaling cascades R-Ras mediates its transforming properties when compared to H-Ras (Osada et al., 1999) , however R-Ras interacts with all three eectors in vitro (Kikuchi et al., 1994; Spaargaren and Bischo, 1994; Urano et al., 1996) . Sequences in the C-terminus of H-Ras have also been investigated for their role in transformation (Willumsen et al., 1986; Hancock et al., 1990; Prior et al., 2001) . These results show that the C-terminal 9 amino acids of HRas involved in post-translational processing are essential for transformation, whereas con¯icting results have been published on the role of the residual amino acids of the hypervariable region (Willumsen et al., 1986; Prior et al., 2001 ). The hypervariable region of H-Ras has, however, been found to be involved in subcellular localization since it is required for translocation of H-Ras from lipid rafts into bulk plasma membrane upon activation (Prior et al., 2001) .
H-Ras and R-Ras have been found to have distinct roles in the regulation of integrin function (Zhang et al., 1996; Sethi et al., 1999; Zou et al., 1999; Kinashi et al., 2000) . Integrins are a family of a/b-heterodimeric adhesion receptors that attach cells to the extracellular matrix or to other cells, and play a key role in cell growth, survival and tumor metastasis (Hynes, 1992; Schwartz et al., 1995) . A characteristic feature of integrins is their ability to dynamically regulate their anity for soluble ligands in response to intracellular signals, a process de®ned as`activation' (Hughes and Pfa, 1998) . The signal cascades involved in this process are poorly understood but several observations suggest that members of the Ras family of small GTPases and their downstream eectors are critically involved in the regulation of integrin activation. H-Ras has been shown to suppress the activation of b 1 and b 3 integrins in Chinese Hamster Ovary (CHO) cells via its eector serine/threonine kinase Raf-1 (Hughes et al., 1997) . In contrast, R-Ras can antagonize this Ras/Raf suppressor pathway, presumably downstream of the ERK/MAP kinase in the signal cascade since R-Ras does not interfere with ERK activation by H-Ras (Sethi et al., 1999) , an activity dependent on the eector region and prenylation signal of R-Ras (Oertli et al., 2000) . In macrophages, R-Ras activates the a m b 2 integrin via the Ras-related protein Rap1 leading to phagocytosis of opsonized red blood cells whereas Ras does not (Caron et al., 2000; Self et al., 2001) . Finally, in ®broblasts, myeloid cells and bone marrow derived mast cells, expression of activated RRas stimulates integrin activation and integrindependent adhesion (Zhang et al., 1996; Keely et al., 1999; Osada et al., 1999; Sethi et al., 1999; Kinashi et al., 2000) . Activation of PI3-kinase is involved in R-Ras stimulation of integrins in haematopoietic and in epithelial cells, but in ®bro-blasts and macrophages, the critical eectors are as yet unidenti®ed (Keely et al., 1999; Kinashi et al., 2000; Oertli et al., 2000) .
Alterations in integrins have been shown to play a role in the phenotype of transformed cells. Studies on rodent cell lines have shown that the level of the integrin a 5 b 1 , a ®bronectin receptor, is reduced in Rastransformed cells compared to normal cells (Plantefaber and Hynes, 1989) and elevated levels of a 5 b 1 can suppress the transformed phenotype of CHO cells, resulting in reduced agar growth and tumor formation in nude mice (Giancotti and Ruoslahti, 1990) . Low ®bronectin matrix levels have long been correlated with a transformed phenotype (Hynes, 1990) , and recently activated Ras has been found to negatively regulate ®bronectin matrix assembly through an ERK-dependent pathway (Brenner et al., 2000) .
A ®nal phenotypic dierence between ®broblast cells expressing H-Ras and R-Ras concerns the response to serum deprivation where H-Ras has been shown to survive growth factor withdrawal (Terada et al., 1995; Chou and Yung, 1997) , whereas activated R-Ras increases the rates of apoptotic cell death in several dierent growth factor-deprived cell lines (Wang et al., 1995) . Apoptosis is a mechanism by which cells are programmed to die and which can be induced by reactive oxygen species (Wyllie, 1997) . The mechanism by which R-Ras mediates apoptosis in serum-deprived ®broblasts is not known.
The sequence dierences through which the dierent activities of H-Ras and R-Ras must be mediated are located mainly in the C-terminal halves, with additional dierences including the regions¯anking the conserved eector core sequence ( Figure 1a ). Earlier structure-function studies between H-Ras and R-Ras have shown that sequences C-terminal of amino acid 111 in R-Ras could abolish the transformation potential in Rat-1 ®broblast when exchanged with the equivalent H-Ras C-terminal residues (Lowe et al., 1988) . These results suggest that these sequences in the C-terminus of H-Ras are necessary but not sucient for the transforming function, although a positive role for the exchanged R-Ras sequences was not reported (Lowe et al., 1988) . In an attempt to further de®ne the decisive dierences, we have constructed a panel of chimeras to contain variable regions of the C-terminus exchanged with R-Ras sequences and a chimera with Nterminal R-Ras sequences and C-terminal H-Ras sequences. We have analysed these for the particular H-Ras or R-Ras-like phenotypes in terms of focus formation, response to serum deprivation, and integrin anity modulation. We have found (1) that the C-terminal 53 amino acids of R-Ras are sucient to confer the contrasting biological properties of RRas to the protein H-Ras in all the biological assays, (2) that the C-terminal 26 amino acids are sucient for directing an R-Ras-speci®c antagonism of H-Rasinitiated integrin suppression, and (3) that the transformation phenotype and capacity to modulate integrin anity can be separated. We also investigated the relationship between morphological transformation of cells and speci®c integrin expression by establishing an integrin pro®le of stable cell pools expressing activated H-Ras and R-Ras. No qualitative dierences were obtained; both types of cell pools expressed the integrin subunits a 5 , a 6 , and b 1 , but not a v , a 4 , or b 4 . The anity state of b 1 was compared and showed that both cell pools had reduced activity, suggesting that reduced b 1 activity is not sucient for the H-Ras-transformed cell morphology at least in this particular ®broblast background.
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Results
An H-Ras chimera containing the 53 C-terminal amino acids of R-Ras elicits an R-Ras phenotype
We wanted to address the role that the C-terminus of R-Ras played in R-Ras function, thus we created chimeras of H-Ras into which dierent segments of the R-Ras C-terminal sequences were inserted ( Figure  1B ). All proteins contained activating mutations and are thus anticipated to be in a constitutive GTPbound form. All recombinant proteins were expressed at similar levels in both CHO and NIH3T3 cells (Figure 2) .
We ®rst examined the ability of the chimeras to induce foci in transformation assays. As noted above, H-Ras transforms a variety of ®broblast types whereas R-Ras has weak focus forming activity in a subset of these cell lines. To assay focus formation, we used two dierent R-Ras focus-de®cient cell lines, NIH3T3 ATCC and NIH3T3 clone 7 cells and one R-Ras focus-positive cell line, the NIH3T3 UNC cells. The molecular basis for their dierence is not known; however, the UNC cells look more morphologically transformed themselves in being more spindle-shaped and refractile compared to the other two. The focus forming activity obtained with R-Ras in the UNC cells is not just quantitatively dierent but also qualitatively dierent since the morphology of the foci as well as of the cells in the single focus of activated H-Ras versus activated R-Ras transfected cells is not the same. The cells in the H-Ras focus are highly refractile and elongated, which are characteristics of a transformed cell. The R-Ras focus is smaller and consists of cells that are round and piled on top of each other. These cells will give rise to cell lines that have untransformed morphology like vector transfected cells (Cox et al., 1994; Figure 3a) . The distinction between H-Ras and R-Ras focus forming activities enabled the use of this cell line to characterize the various hybrid proteins for potential R-Ras-like transformation characteristics; it is not known, however, if the R-Ras transformation phenotype in UNC cells is speci®c or rather a partial H-Ras-like transformation.
Because of the sequence divergence in the C-termini of these proteins (Figure 1a) , we ®rst exchanged the 51 C-terminal amino acids of H-Ras with the equivalent 53 amino acids of R-Ras to form the HR139 chimera (Figure 1 ). This chimera showed no focus forming activity in R-Ras focus-negative cell lines, but did form foci at a level comparable to the one of R-Ras in the R-Ras sensitive UNC cell line (Table 1 ). The HR139-induced foci resembled R-Ras 38V foci in size and the cells constituting the foci looked untransformed and stable cell pools expressing this construct also had nontransformed characteristics compared to the highly transformed v-H-Ras cells ( Figure 3a) .
As mentioned, the transformation assay may not distinguish an R-Ras speci®c response from a weak HRas response. Therefore, we sought to investigate the HR139 chimera with potential R-Ras speci®city in an alternative R-Ras-positive assay. Activated R-Ras has been shown to increase the rate of apoptotic cell death in serum-deprived ®broblasts (Wang et al., 1995) ; in addition, R-Ras 38V expressing ®broblasts respond to serum deprivation by undergoing a process that resembles that of apoptosis since these cells detach and become granulated, whereas normal cells appear to die by a process that looks more like necrosis (data not shown). To address the possibility of an apoptotic death response by R-Ras, we stained starved cells prior to their detachment for the presence of reactive oxygen species (ROS). Stable pools of R-Ras transfected cells exhibited a high level of ROS following serum starvation whereas vector and H-Ras transfected cells did not. The HR139 line showed a high level of ROS staining, comparable to that of R-Ras, suggesting that the 53 C-terminal amino acids are sucient to convey this R-Ras speci®c phenotype of ROS induction to H-Ras.
Other C-terminal chimeras carrying smaller exchanged regions show H-Ras characteristics
In order to narrow down the region in R-Ras that confer Ras-like biological properties on H-Ras, several other chimeras were constructed that contain subsegments of the 53 C-terminal amino acids ( Figure 1b ). These chimeras were designed to cover various regions previously found to be either essential or dispensable for the transforming activity of v-H-Ras (Willumsen et al., 1986 (Willumsen et al., , 1991 . All these chimeras showed an H-Raslike transforming phenotype since they transformed both R-Ras focus-negative and R-Ras focus-positive cell lines to the same degree as did v-H-Ras (Table 1) . The morphology of the foci obtained with these chimeras was similar to those elicited by H-Ras (data not shown). An H-Ras chimera comprising the most divergent amino acids 121 ± 138 of R-Ras (HR121 ± 138) also retained H-Ras activity in focus forming assays (Table 1) ; thus exchange of the entire C-terminal 53 amino acids was required to convey R-Ras transforming properties to H-Ras.
As an additional characteristic, the chimeras were examined for transcriptional activation of the fos promoter, one of several genes shown to be activated by constitutive ras activation (Stacey et al., 1987; Sassone-Corsi et al., 1989) . All new chimeras induced a c-fos luciferase reporter to the same degree as did v-Hras (Figure 4) , further supporting the ®nding that these chimeras possess H-Ras-like biological properties.
Integrin analysis of H-and R-Ras expressing cells
Integrins are transmembrane receptors which mediate the formation of focal adhesions in which they link the outside matrix to the intracellular cytoskeletal complexes. These complexes play a role in modulating cell adhesion, cell shape, and cell motility (Kumar, 1998) , which are all characteristics changed in a transformed cell. We therefore pro®led stable cell pools expressing v-H-Ras and R-Ras 38V in NIH3T3 UNC cells for integrin subunit expression in order to characterize the dierences in the observed morphology in more detail. v-H-Ras and R-Ras 38V cells both expressed the b 1 , a 5 and a 6 integrin subunits, b 1 levels were slightly reduced in both of the Ras transformed cell lines compared to vector cells ( Figure 5a) ; none of the cells examined expressed a v , a 4 , or b 4 (data not shown).
We assessed the activity state of ®bronectin binding integrins by measuring the ability of the cells to bind a soluble fragment of ®bronectin, FN 9-11, composed of glutathione S transferase (GST) and the 9, 10, and 11 type III repeats of ®bronectin, which make up the RGD-containing central cell binding domain of ®bronectin (Ramos and DeSimone, 1996) . The level of FN 9-11 binding divided by the expression level of the b 1 subunit is then a measure of the b 1 activity state. Transformed v-H-Ras cells showed a signi®cant decrease in the level of FN 9-11 binding (60% of the level of vector-transfected cells). Interestingly, the RRas 38V transformed cells also showed a decrease in ®bronectin binding (to 70% of vector cells), suggesting that reduced integrin activation is not sucient for the morphological transformation elicited by v-H-Ras at least in the NIH3T3 UNC cell background. This ®nding was further supported by the ®nding that no morphological changes in v-H-Ras cells were observed after treating plates with the activating anti-b 1 antibody 9EG7 before seeding to ensure full activation of b 1 receptors (data not shown). In addition, we treated the cell pools with the MEK inhibitor U0126 and determined FN 9-11 binding properties of the cells; the treatment with the inhibitor did not lead to any change in the level of FN 9-11 binding despite clear reversion of the v-H-Ras induced cellular morphology (data not shown).
PAC binding induced by chimeras in abpy-cells does not correlate with transformation morphology
As an additional assay of the eects of H-Ras and RRas on integrins we used ab-py cells. In these cells, the GTPases have opposing eects on integrin activation
Oncogene Structure-function analysis of H-Ras and R-Ras M Hansen et al as measured by the binding of the activation speci®c monoclonal antibody, PAC1, to a chimeric aIIbb3 integrin (Hughes et al., 1997; Sethi et al., 1999) . As reported previously, we found that transfection with activated H-Ras suppressed integrin activation, whereas activated R-Ras did not suppress (not shown), and reversed the eect of H-Ras (Figure 6a ).
The set of chimeras was investigated for the ability to suppress integrin activation and reverse H-Rasinduced integrin suppression as H-Ras-and R-Ras- Stable cell pools were established by transfecting NIH3T3 UNC cells with expression plasmids encoding the various proteins or an empty vector control followed by selection for the G418 marker. Plates containing more than 50 independent G418 resistant colonies were trypsinized to establish stable cell pools. Magni®cation, 1006. (b) Reactive oxygen species (ROS) production assay. Stable cell pools expressing activated versions of the indicated proteins were starved for 14 h and stained for the presence of reactive oxygen species with a¯uorescent peroxide-sensitive dye and observed in a laser confocal microscope. Magni®cation, 1006
Structure-function analysis of H-Ras and R-Ras M Hansen et al speci®c activities, respectively. All chimeras except HR139 and HR166 strongly suppressed integrin activation (Figure 6b ). Importantly, HR166 manifested H-Ras-like transformation characteristics, but did not suppress activation. Thus, this chimera provides a clear separation between H-Ras transformation morphology and the ability to suppress integrin activation. The two chimeras de®cient for suppression abilities were investigated for their ability to reverse H-Ras-induced suppression. HR139 and HR166 were both found to reverse the integrin suppression to the same level as did R-Ras 38V (Figure 6c ), suggesting that sequences in the 30 C-terminal amino acids of R-Ras are sucient to specify the R-Ras-speci®c integrin anity modulation. The R-Ras-speci®c reversal phenotype has been shown to be ERK-independent; this was also suggested to be the mechanism by which at least chimera HR139 works since this construct, which does not activate ERK eciently on its own (see later), did not inhibit ERK activation in the presence of H-Ras (data not shown), suggesting that the rescue is not just simply occurring through a nonfunctional titration of this mediator of the suppression response (Hughes et al., 1997) .
RH137 chimera suppresses integrin activation but shows R-Ras-like transformation properties
The preceding studies identi®ed an H-Ras chimera (HR166) that failed to suppress integrin activation (RRas-like), but transformed cell lines, induced transcriptional activation and had morphological eects similar to those elicited by H-Ras. A chimera described earlier by Lowe and coworkers was also investigated and compared with regard to transformation and phenotype in the PAC assay. This chimera, named p23 val V, consists of R-Ras sequences from amino acid 1 to 136 and C-terminal H-Ras sequences downstream of amino acid 137. Like parental R-Ras, the chimera was found not to be able to transform Rat-1 ®broblasts or to induce soft agar growth (Lowe et al., 1988) .
We recreated the chimera and renamed it RH137. We found that RH137 was able to transform NIH3T3 UNC cells to a level comparable to activated R-Ras and the morphology of the foci resembled the morphology of R-Ras foci (Table 2 and Figure 7a ). This construct was, however, able to suppress integrin activation as eciently as v-H-Ras (Figure 7b) . Thus, H-Ras C-terminal sequences are not sucient to confer full H-Ras speci®city to R-Ras, in contrast to the vice versa situation transferring R-ras sequences into H-ras. These data show that the integrin and transformation phenotypes are separable and that H-Ras C-terminal sequences are involved in directing integrin suppression.
ERK activity correlates with fully transformed morphology and the presence of H-Ras N-terminal sequences Activated H-Ras has been shown to lead to activation of ERK whereas R-Ras does not (Marte et al., 1996; Hu et al., 1997; Osada et al., 1999) . As a measure of H-Ras activity, the level of ERK activity was assessed in transient transfection studies by investigating the ability of the constructs to mediate the phosphorylation of ERK using a phospho-speci®c antibody against ERK1 and ERK2 (Figure 8a ). All chimeras showed some degree of activity compared to activated H-Ras, Table 1 Focus forming activity of C-terminal chimeras Figure 4 Transcriptional activation of c-fos promoter correlates with transformation phenotype. c-fos promoter activation in serum-starved NIH3T3 UNC cells using a c-fos-luciferase construct as a reporter in a transient transfection assay. Promoter activity is related to the level of the vector control and presented as average of duplicate estimates+s.e.m. The experiment was repeated three times with equivalent results. All constructs carry activating mutations
Oncogene Structure-function analysis of H-Ras and R-Ras M Hansen et al however, HR139 consistently showed a somewhat lower level of activation compared to the other chimeras. The use of the phospho-antibody did not allow for an actual quantitative comparison of the relative ERK levels, especially since the level of transfected HA-ERK2 varied slightly, however, the same ERK activation pro®le was observed on lysates made from stable cell pools expressing the various chimeras (data not shown). The RH137 gave no ERK activity (Figure 8b) , suggesting that the presence of Nterminal H-Ras sequences is required for induction of ERK activity. The correlation between ERK activity and H-Ras transformed phenotype re-emphasizes the importance of this activity for the focus-morphology. The characteristics of all parental and chimeric molecules are summarized in Table 3 .
Discussion
Despite their sequence similarities, H-Ras and R-Ras exhibit distinct biological properties when expressed in mammalian cells. R-ras is only able to transform a subset of those ®broblast cell lines in which activated H-ras form foci, and R-Ras transformed NIH3T3 cells display less of the morphological eects associated with Cox et al., 1994; Saez et al., 1994) . The basis for the dierences between H-Ras and R-Ras transforming abilities is not known, and particularly it is not known whether the R-Ras transforming properties are unique rather than re¯ecting an impaired H-Ras response. However, the focus assay in the NIH3T3 UNC cells clearly distinguishes between H-ras and R-ras, since Rras gave characteristic, small foci. HR139, consisting of H-Ras N-terminal sequences from amino acid 1 ± 138 with the residual sequences exchanged with the complementary 53 R-Ras C-terminal amino acids, was the only C-terminal chimera with R-Ras-like transformation properties; all others gave rise to HRas-like foci and cells. This observation extends the ®nding by Lowe et al. (1988 ) that a chimera consisting of H-Ras sequences from amino acid 1 to 110 and Cterminal R-Ras sequences showed loss of H-Ras-like transformation properties in Rat-1 cells (in which Rras was not focus-forming), leading to the conclusion that sequences in the C-terminus of H-Ras are necessary but not sucient for the transforming function of H-Ras. Our R-Ras N-terminal chimera, RH137 (110 in H-Ras numbering), shows an R-Raslike transformation phenotype; this chimera was recreated to be equivalent to another construct reported by Lowe et al. (1988) , which was found to have lost H-Ras transforming abilities. The chimera HR139 (Figure 1 ) was found to possess R-Ras-like phenotypes since (1) HR139 showed R-Ras-like transformation properties in NIH3T3 UNC cells; (2) HR139 was able to reverse H-Ras-mediated integrin suppression to the same degree as activated R-Ras; and (3) stable cell pools expressing HR139 contained elevated levels of reactive oxygen species (ROS) following serum deprivation. The production of ROS in response to serum deprivation was speci®c for RRas since activated H-Ras did not induce similar intracellular levels of ROS upon growth factor withdrawal; this ®nding is in agreement with the observation of R-Ras expressing ®broblasts to respond to serum deprivation by apoptosis (Wang et al., 1995) . Consequently, the data obtained with the chimera HR139 suggest speci®city can be directed by the Cterminus of R-Ras. From studies on related GTPases, the C-terminal region is assumed to contain the signals leading to the post-translational modi®cations that are responsible for membrane attachment (Willumsen et al., 1986; Hancock et al., 1990) , as well as the heterogeneous region, a region where even the N-, H-, and K-Ras proteins diverge fully, in spite of their similar biological phenotypes. A chimera created to test the possibility of a unique R-Ras speci®c membrane attachment encoded in the C-terminal 9 amino acids, HR181, showed that R-Ras sequences can substitute for H-Ras membrane attachment sequences without conferring the R-Ras phenotypes. Chimeras HR139-165 and HR166-180, which exchange the residual segments of the R-Ras sequences present in HR139, also did not confer an R-Ras phenotype, suggesting that the full sequence functions as an entity, in spite of the minimal sequence divergence in the region between 139 and 165. The speci®city directed by the C-terminus of R-Ras could be speculated to originate from speci®c subcellular localization, directed by the sequence. The hypervariable region of H-Ras has been found to be involved in subcellular localization since it is required for translocation of H-Ras from lipid rafts into bulk plasma membrane upon activation; the release of HRas from rafts is necessary for ecient activation of the eector Raf (Prior et al., 2001) . Thus, R-Ras might localize dierently in the plasma membrane compared to H-Ras and thereby interact with a unique set of eectors to mediate its speci®c biological phenotypes. Such unique eectors could be hypothesized to interact with R-Ras as a result of the acquired tertiary structure of the GTPase in the membrane micro-domain; the conformation could promote interaction with eectors in the eector domain or, alternatively, directly in the C-terminal region. In addition, the eector(s) could be physically restricted to the speci®c membrane compartment. We are currently investigating and comparing the membrane localization of R-Ras with that of HRas.
The chimera HR166 exhibited a mixed phenotype in that it was R-Ras-like with respect to antagonizing HRas-initiated integrin suppression, but H-Ras-like with respect to transformation. This chimera encodes the Cterminal 26 amino acids of R-Ras, thus, when amino acids 139 ± 165 were changed to H-Ras, the R-Ras speci®c integrin phenotype was retained in a context of the full transformation phenotype of H-Ras. The RH137 chimera showed the converse combination: potent suppression of integrin activaction in the context of R-Ras-like transformation. Thus, the RRas speci®c phenotypes are separable and suggest that dierent eectors could be mediating the two responses. Such eectors could, as suggested above, be dependent on the C-terminal sequences of the GTPase for interactions and optimal function.
ERK activity plays an active role in Ras transformation (Cowley et al., 1994; Khosravi-Far et al., 1998) . This activation arises mainly through activation of Raf, an event dependent on Ras-Raf interaction through the eector region (amino acids 25 ± 45) of Ras (Marais et al., 1995) . All H-Ras/R-Ras chimeras with an H-Ras transforming phenotype were able to elicit ERK activity in transfected cells. The HR139 mutant, which gave R-Ras-like small foci in NIH3T3 UNC (and none in the other two NIH3T3 sublines used), induced signi®cant, but reduced, phospho-ERK levels. Thus, the R-Ras-like transformation phenotype appears to occur in the presence of at least some functional signaling to ERK.
Activation of ERK by Ras has been implicated in the suppressive integrin response that H-Ras can mediate (Hughes et al., 1997) ; however, ERK activity was found not to be required for suppression since a chimera which gave rise to a potent suppression of integrin activity (RH137) showed no ERK activity. That RH137 was competent for suppression of integrin activity suggested that sequences in the C-terminus of H-Ras are required for suppressive regulation of integrin function; this is further supported by investigation of additional constructs (Hughes et al., 2002) .
Alterations in integrin expression have been shown to play a role in the phenotype of transformed cells. We found that both H-Ras and R-Ras expressing NIH3T3 UNC ®broblasts expressed the same levels of the a 5 and a 6 integrin subunits but a slightly lower level of the b 1 integrin subunit compared to vector transfected cells. The dierence in b 1 expression levels was consistent with the ®nding that the activity state of the b 1 integrin subunit was reduced for both activated H-Ras and R-Ras expressing cells. These results dier from the ®nding that rodent transformed cells have reduced levels of the a 5 subunit and unchanged levels of the b 1 subunit compared to normal cells (Plantefaber and Hynes, 1989) ; indeed, there seems to be no correlation between the level of the integrin subunits a 5 and b 1 and a transformed cell morphology since Raf activation in NIH3T3 cells have been shown to induce the levels of a 5 and b 1 , along with other integrin subunits, most notably b 3 (Woods et al., 2001) . The level of integrin a 6 has been reported to correlate with (Lin et al., 1993) and a 6 levels are signi®cantly elevated in ®broblasts overexpressing activated Ras (Jasiulionis et al., 1996) . We detected expression of a 6 in the NIH3T3 UNC cells, as well as in ATCC and clone 7 ®broblasts (data not shown), but did not ®nd any dierences in the levels of a 6 compared to UNC cells expressing either activated H-Ras or R-Ras. The divergent transforming potentials of the two small GTPases can therefore not be explained simply by dierent activity levels of the integrin b 1 sequences or in expression levels of yet other integrin subunits, e.g. a 6 .
The transforming activity of R-ras could be viewed as a poorly penetrating transforming activity, where several structural changes might result in the characteristic small R-Ras foci. In this light, such interfering sequences might lie both in the N-terminus (as demonstrated by RH137) and in the 139 ± 165 sequence (as demonstrated by the R-Ras foci of HR139). The interfering sequences could aect speci®c binding of eectors involved in transformation. In HRas the 139 ± 165 sequences form a surface on the protein onto which so far no interactions have been mapped, whereas several eectors important for transformation have been identi®ed to bind to the eector region of H-Ras, but not R-Ras. The morphology of foci observed for the G37 and C40 eector mutants of H-Ras (Khosravi-Far et al., 1996) , which, like R-Ras, are incapable of Raf binding and which interact with and activate RalGDS and PI3-kinase, respectively (Rodriguez-Viciana et al., 1994) , is in agreement with such a loss-of-function hypothesis. Foci induced by these mutants resemble Rac and Rhoinduced foci which are dense and non-refractile (Khosravi-Far et al., 1996) . The reverting activity of R-Ras on the integrin suppression of H-Ras could be viewed as an interfering activity of R-Ras. Since R-Ras does not revert the suppressive activity of Raf and does not block H-Ras-induced ERK activity, the interference would be downstream of ERK in the Ras/Raf/ ERK pathway or in a dierent pathway. The activity could be dependent on R-Ras sequences leading either to the formation of a complex or to such a common 
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Our data localize such sequences to the C-terminus, being`active' in both HR139 and HR166, both of which are able, like R-Ras, to revert the H-Ras integrin suppressive activity. These sequences, comprising the heterogeneous sequences distinguishing the H-, N-and K-Ras proteins and the sequences directing the posttranslational modi®cations leading to membrane association, may direct further localization within the structures of the membrane.
Materials and methods

Antibodies and reagents
The isolation and characterization of the anti-a IIb b 3 monoclonal antibody anti-LIBS6 were previously described . The activation-dependent anti-a IIb b 3 monoclonal antibody PAC1 (Shattil et al., 1985) (Furth et al., 1982) were both prepared from ascites. Monoclonal antibodies against HA-tag and phospho-ERK1/ 2 were obtained from Santa Cruz Biotechnology, Inc. (USA). The MEK kinase inhibitor U0126 was obtained from Promega, USA.
cDNA constructs and cell lines
The mammalian pGV16-derived expression vector pBW1423 containing v-H-ras (H-Ras with mutations G12R, A59T) has previously been described (Jhappan et al., 1986; Willumsen et al., 1991) . This construct expresses the v-H-ras gene from a Moloney Sarcoma virus LTR and carries the gene giving resistance to G418. R-Ras 38V was ampli®ed by PCR from pZBRII-R-Ras 38V (made by Geo Clark, NIH, Bethesda, USA) and cloned into the pGV16-derived vector to give pMH15. The H-Ras/R-Ras chimeras were constructed using splice-overlap PCR mutagenesis with pBW1423/v-H-Ras and pMH15/R-Ras 38V as templates. Some of the chimeras were also made in an H-Ras 12R or in an H-Ras 12R, 61K background. These mutants as well as the parental proteins were compared in the various assays and found to possess the same activity and are therefore not dierentiated in the result section. Mutations were made using oligonucleotide directed copying of deoxyuridine containing M13 derived template with minor modi®cations (Willumsen, 1995) of the method described by Kunkel (1985) . DNA sequencing prior to further analysis veri®ed all chimeras and mutants. The LTR-based pGV16-derived expression vector was used for transformation assays and transactivation assays. For PAC assays and ERK investigations, the constructs were subcloned into a pCDNA3 vector (Invitrogen, USA) modi®ed to contain a FLAG tag (amino acid sequence MDYKDDDDK, one letter code). The mammalian expression vector encoding HA-ERK2 has been described previously (Sethi et al., 1999) . NIH3T3 UNC cells were obtained from Channing Der, UNC-CH, through the AD Cox laboratory. NIH3T3 clone 7 cells were from Doug Lowy, NIH. Chinese Hamster Ovary (CHO)-K1 and NIH3T3 ATCC CRL 1658 cells were obtained from the American Type Culture Collection. The generation of CHO ab-py cells has been described previously (Baker et al., 1997) . These cells stably express the polyoma large T antigen and bear a recombinant chimeric integrin that has the extracellular and transmembrane domains of integrin a IIb b 3 joined to the cytoplasmic domains of integrin a 6A b 1A (a IIb a 6 b 3 b 1 ). Cells were cultured in DMEM (BioWhittaker, USA) containing 10% fetal calf serum, 10% newborn bovine serum (NIH ATCC), or 10% calf serum (NIH3T3 UNC) (Gibco BRL, USA), 1% non-essential amino acids (only CHO cells), 2 mM glutamine (Sigma, USA), 100 U/ml penicillin and 100 mg/ml streptomycin (Gibco BRL).
Flow cytometry
PAC1 binding was measured by two-color¯ow-cytometry as described previously (Hughes et al., 1997) . Brie¯y, ab-py cells were transiently transfected with 2 mg of each Ras construct and 1 mg Tac-a5 vector (encodes the extracellular domain of the interleukin-2 receptor (LaFlamme et al., 1992) , serves as transfection marker) using Lipofectamine (Gibco BRL, USA). Cells were harvested 48 h after transfection by trypsinizing brie¯y and washed in DMEM/1% BSA. 5610 5 cells were incubated with 0.1% PAC1 ascites in the presence of the competitive inhibitor Ro43-5054 at 1 mM or a IIb b 3 -activating antibody anti-LIBS6 ascites. After a 30 min incubation period at room temperature, cells were washed with cold DMEM/1% BSA and incubated with the biotinylated anti-Tac antibody 7G7B6 for 30 min on ice. After washing, cells were incubated with 10% FITCconjugated goat anti-mouse IgM (TAGO, USA) and 4% phycoerythrin-streptavidin (Molecular Probes Inc., USA, chromophore-conjugated molecule) for another 30 min on ice. Cells were washed in ice-cold PBS and resuspended in PBS. Then cells were analysed on a FACScan (Becton Dickinson, USA)¯ow cytometer as described (Hughes et al., 1997) and the collected data analysed using CellQuest software (Becton Dickinson, USA).
To obtain numerical estimates of integrin activation, an activation index (AI), de®ned as 1006(F o ± F r )/(F o LIBS6 ± F r ), was calculated where F o is the median¯uorescence intensity (MFI) of PAC1 binding; F r is the MFI of PAC1 binding in the presence of competitive inhibitor (Ro43-5054, 1 mM); and F o LIBS6 is the MFI of PAC1 binding in the presence of a IIb b 3 -activating antibody (anti-LIBS6, 2 mM). Per cent suppression was calculated as 100(AI o -AI)/AI o , where AI o is the activation index in the absence of the cotransfected test cDNA, and AI is the activation index in its presence.
Oncogene Structure-function analysis of H-Ras and R-Ras M Hansen et al Fibronectin binding capacity was assayed by using the reagent FN 9-11 in a two-color¯ow cytometry set-up. FN 9-11 refers to a soluble fragment of ®bronectin, here fused to glutathione S transferase (GST) (Ramos and DeSimone, 1996) . Cells were harvested by brief trypsination, followed by neutralization with the addition of complete media. Cells were then pelleted by a brief centrifugation, washed, and resuspended in Tyrodes/HEPES buer (Tyrodes buer: 144 mM NaCl, 12 mM NaHCO 3 , 2.6 mM KCl; Tyrodes-HEPES buer: Tyrodes buer with 10 mM HEPES, 2 mM MgCl 2 , 1 mg/ml BSA, 1 mg/ml dextrose). The harvested cells were then aliquoted into three pools containing either Tyrodes/HEPES buer alone, Tyrodes buer plus 5 mM EDTA, and Tyrodes/HEPES buer plus the activating antib 1 monoclonal antibody 9EG7 (10 mg/ml) (Pharmingen, USA). The cells were then incubated for 15 min at room temperature. Following the addition of biotinylated GST FN 9-11 the cells were incubated at room temperature for a further 15 min. After washing in ice cold Tyrodes, the cells were incubated on ice for 30 min with 4% phycoerythrinstreptavidin (Molecular Probes Inc., USA). The cells were then washed in ice cold Tyrodes and analysed on a FACScan (Becton Dickinson, USA)¯ow cytometer. The collected data were analysed using CellQuest software (Becton Dickinson, USA). To obtain numerical estimates of b 1 integrin anity, an activation index (AI), de®ned as 1006 (F sample ± F 0 )/(F total ± F 0 ), was calculated where F o is the median¯uorescence intensity (MFI) of FN 9-11 binding in the presence of the metal ion chelator EDTA; F sample is the MFI of FN 9-11 binding of the sample in the presence of buer only; and F total is the MFI of FN 9-11 binding in the presence of the activating anti-b 1 monoclonal antibody 9EG7 (Pharmingen, USA).
Measurement of ERK phosphorylation
CHO cells were transfected using Lipofectamine (Gibco BRL, USA) as described , using 2 mg of each Ras/ R-Ras construct and 1 mg HA-ERK2 construct per 10 cm dish. Transfections were performed in duplicate to allow for parallel analysis of both ERK phosphorylation and PAC1 binding bȳ ow cytometry. Twenty-four hours following transfection, the cells were washed and placed in medium containing 0.5% fetal calf serum. Cells were washed 48 h after transfection and lysed in a buer containing a mixture of protease and phosphatase inhibitors (Hughes et al., 1997) . Phosphorylated ERK was detected by fractionating 20 mg of whole cell lysate on 4 ± 20% SDS-polyacrylamide gels, transferring to nitrocellulose membranes and immunoblotting with a monoclonal antibody that recognizes only the phosphorylated forms of ERK1 and ERK2 (Santa Cruz Biotechnology, USA). We consistently found that phosphorylated endogenous ERK-2 was also readily detectable whereas phosphorylated endogenous ERK-1 only occasionally showed up as a more faint band migrating in between phosphorylated bands of HA-ERK and endogenous ERK-2 (data not shown). The blots were stripped and immunoblotted with the monoclonal antibody recognizing the HA-epitope (Santa Cruz Biotechnology, USA) to determine the amount of HA-ERK2 present in each of the lysates.
Assay for reactive oxygen species
Intracellular levels of reactive oxygen species were measured using the¯uorescent peroxide-sensitive dye 2',7'-dichlorohydro¯uorescein diacetate (H2DCFDA; Molecular Probes, USA). NIH3T3 cells stably expressing the various constructs were grown at equal density on No.1 thickness glass coverslips (Nunc, USA) for 24 h. The complete medium was subsequently replaced by 0.5% CS/DMEM and cultures were starved for 14 h. The coverslips were washed twice in Hank's Buered Saline Solution (HBSS, Gibco-BRL, USA) lacking phenol red and incubated in 10 mM of fresh H2DCFDA in HBSS for 15 min at room temperature. Images were immediately collected on a laser confocal microscope (Leica TCS-NT, Leica, USA) using a longpass ®lter of 515 nm.
Transformation assay and stable cell lines
Focus forming activity was measured in UNC, ATCC and clone 7 NIH3T3 cells. Transfections for obtaining quantitative data were performed as described (Willumsen, 1995) : NIH3T3 cells were transfected with 200 ng pGV16-derived expression plasmids encoding v-H-Ras, R-Ras 38V or various chimeras. DNA was added as a CaCl 2 precipitate to 2.2610 5 cells. The next day the cells were split and seeded onto 10 cm dishes, some of which were scored for focus formation and others for development of G418 resistant colonies. For each experimental condition, transforming activity was determined as foci per 1000 G418 colonies. Within each experiment, the relative activity of the mutants was determined by comparison with that of the v-H-ras gene. 5 ± 10 000 G418 colonies per mg DNA were obtained for clone 7 and ATCC cells, whereas 10 ± 20 000 G418 colonies per mg DNA were obtained for UNC cells. The v-H-ras gene transformed with an eciency between 200 ± 500 foci per G418 colonies for all cell lines. Cells from at least 50 G418 selected colonies were pooled to generate stable cell pools; these were found to express similar levels of the transfected protein.
Transient transactivation reporter assay
NIH3T3 UNC cells were seeded onto 35 mm dishes for transactivation assays and transfected using Lipofectamine with 1 mg construct, 0.5 mg of the c-fos ®re¯y luciferase reporter gene and 0.2 mg pRL-NULL renilla luciferase reporter (Promega, USA) gene as an internal standard. The ®re¯y reporter gene is under the control of a segment spanning 7710 bp to +42 bp of the fos promoter. After 24 h, cells were starved in 0.5% serum, and the levels of luciferase activity in cell lysates were determined after another 24 h using the Promega Dual Luciferase system according to the manufacturer's instructions. Relative luciferase units (RLU) were normalized to those detected with vector alone and reported as fold activation.
